Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B0IO
|
||||
| Former ID |
DNC010427
|
||||
| Drug Name |
Nicotinaldehyde O-4-ethoxyphenylcarbamoyl oxime
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula |
C15H15N3O3
|
||||
| Canonical SMILES |
CCOC1=CC=C(C=C1)NC(=O)ON=CC2=CN=CC=C2
|
||||
| InChI |
1S/C15H15N3O3/c1-2-20-14-7-5-13(6-8-14)18-15(19)21-17-11-12-4-3-9-16-10-12/h3-11H,2H2,1H3,(H,18,19)/b17-11+
|
||||
| InChIKey |
LKOKEOYUZBYMCC-GZTJUZNOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.